Astec LifeSciences Past Earnings Performance
Past criteria checks 0/6
Astec LifeSciences's earnings have been declining at an average annual rate of -10.2%, while the Chemicals industry saw earnings growing at 16.6% annually. Revenues have been growing at an average rate of 6.4% per year.
Key information
-10.2%
Earnings growth rate
-10.2%
EPS growth rate
Chemicals Industry Growth | 17.7% |
Revenue growth rate | 6.4% |
Return on equity | -12.9% |
Net Margin | -11.8% |
Next Earnings Update | 02 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Astec LifeSciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 4,317 | -509 | 610 | 0 |
30 Sep 23 | 4,981 | -258 | 579 | 0 |
30 Jun 23 | 5,871 | 60 | 557 | 0 |
31 Mar 23 | 6,285 | 256 | 533 | 0 |
31 Dec 22 | 7,735 | 736 | 571 | 0 |
30 Sep 22 | 8,297 | 975 | 586 | 0 |
30 Jun 22 | 7,325 | 883 | 550 | 0 |
31 Mar 22 | 6,769 | 899 | 513 | 0 |
31 Dec 21 | 5,803 | 708 | 447 | 0 |
30 Sep 21 | 5,230 | 531 | 418 | 0 |
30 Jun 21 | 5,754 | 619 | 402 | 0 |
31 Mar 21 | 5,587 | 650 | 394 | 0 |
31 Dec 20 | 5,698 | 723 | 379 | 0 |
30 Sep 20 | 5,786 | 774 | 354 | 0 |
30 Jun 20 | 5,639 | 648 | 331 | 0 |
31 Mar 20 | 5,287 | 475 | 309 | 0 |
31 Dec 19 | 4,844 | 291 | 280 | 0 |
30 Sep 19 | 4,781 | 269 | 274 | 0 |
30 Jun 19 | 4,507 | 331 | 263 | 0 |
31 Mar 19 | 4,382 | 357 | 262 | 0 |
31 Dec 18 | 4,246 | 402 | 261 | 0 |
30 Sep 18 | 3,781 | 374 | 248 | 0 |
30 Jun 18 | 3,611 | 325 | 235 | 0 |
31 Mar 18 | 3,676 | 349 | 229 | 0 |
31 Dec 17 | 3,254 | 212 | 236 | 0 |
30 Sep 17 | 3,119 | 148 | 228 | 0 |
30 Jun 17 | 3,008 | 192 | 226 | 0 |
31 Mar 17 | 2,987 | 191 | 213 | 0 |
31 Dec 16 | 3,167 | -29 | 188 | 0 |
30 Sep 16 | 2,865 | -114 | 193 | 0 |
30 Jun 16 | 2,643 | -206 | 182 | 0 |
31 Mar 16 | 2,330 | 50 | 163 | 0 |
31 Dec 15 | 2,629 | -115 | 282 | 2 |
30 Sep 15 | 2,777 | 61 | 254 | 2 |
30 Jun 15 | 2,728 | 84 | 129 | 0 |
31 Mar 15 | 2,669 | 148 | 134 | 0 |
31 Dec 14 | 2,212 | 131 | 218 | 3 |
30 Sep 14 | 2,147 | 127 | 217 | 3 |
30 Jun 14 | 2,156 | 96 | 117 | 0 |
31 Mar 14 | 2,070 | 87 | 212 | 3 |
31 Dec 13 | 2,179 | 97 | 184 | 5 |
30 Sep 13 | 2,076 | 76 | 182 | 5 |
30 Jun 13 | 1,849 | 72 | 174 | 5 |
Quality Earnings: 533138 is currently unprofitable.
Growing Profit Margin: 533138 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 533138 is unprofitable, and losses have increased over the past 5 years at a rate of 10.2% per year.
Accelerating Growth: Unable to compare 533138's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 533138 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-6.1%).
Return on Equity
High ROE: 533138 has a negative Return on Equity (-12.88%), as it is currently unprofitable.